The Cooper Companies, Inc. $COO Shares Bought by Aberdeen Group plc

Aberdeen Group plc boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 8.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 164,041 shares of the medical device company’s stock after buying an additional 13,149 shares during the period. Aberdeen Group plc owned 0.08% of Cooper Companies worth $13,445,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in COO. Wellington Management Group LLP increased its position in Cooper Companies by 332.9% during the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after buying an additional 4,756,178 shares during the period. JANA Partners Management LP acquired a new position in Cooper Companies during the third quarter worth approximately $166,917,000. Capital World Investors boosted its stake in shares of Cooper Companies by 25.7% during the third quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock worth $723,417,000 after buying an additional 2,159,233 shares during the period. Ameriprise Financial Inc. boosted its stake in shares of Cooper Companies by 98.8% during the second quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock worth $241,120,000 after buying an additional 1,683,561 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its stake in shares of Cooper Companies by 96.9% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock worth $212,519,000 after buying an additional 1,525,693 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Down 0.9%

Shares of COO opened at $69.66 on Wednesday. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The firm’s 50-day moving average is $77.24 and its two-hundred day moving average is $76.41. The Cooper Companies, Inc. has a twelve month low of $61.78 and a twelve month high of $89.83. The firm has a market capitalization of $13.59 billion, a P/E ratio of 34.49, a PEG ratio of 1.81 and a beta of 1.07.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same period in the prior year, the business posted $0.92 earnings per share. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the subject of several recent research reports. William Blair upgraded shares of Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. Citigroup decreased their target price on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a research note on Friday, March 6th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Barclays increased their target price on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, March 6th. Finally, The Goldman Sachs Group reiterated a “sell” rating and set a $73.00 target price on shares of Cooper Companies in a research note on Friday, January 9th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $90.79.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.